- Severe symptoms (seizure, coma, vomiting, confusion) → 3% saline 100–150 mL IV over 10–20 min, repeat up to 2–3× → aim +4–6 mEq/L in a few hours.
- Correction limit: ≤8 mEq/L per 24 h in high-risk patients (Na ≤105, alcohol use, malnutrition, hypokalemia, liver disease); ≤10–12 in others.
- Check Na every 2–4 h during active correction. Watch urine output — a big water diuresis = rapid rise.
- Overcorrecting? → D5W + desmopressin 2 mcg IV to re-lower.
- Work out the cause: serum osm → urine osm → urine Na → volume status.
Pathophysiology in 60 seconds
⌄
- Hyponatremia is almost always a water problem: too much ADH or too little solute intake.
- Low serum Na → water moves into brain cells → cerebral edema (acute) → seizures.
- After 48 h the brain adapts by losing osmolytes. Fast correction then pulls water out → osmotic demyelination (ODS): dysarthria, dysphagia, quadriparesis, "locked-in" — days later.
Think of the brain as a sponge that slowly squeezed itself smaller to fit. Refill the room too fast and the sponge tears.
Diagnosis
⌄
High/normal osm
glucose, mannitol, pseudo (lipids/protein)
glucose, mannitol, pseudo (lipids/protein)
Low osm (<275)
true hypotonic
true hypotonic
→ next: urine osm
U-osm <100
primary polydipsia, beer potomania, tea & toast
primary polydipsia, beer potomania, tea & toast
U-osm >100 → urine Na
U-Na <30
low effective volume: GI loss, HF, cirrhosis, nephrotic
low effective volume: GI loss, HF, cirrhosis, nephrotic
U-Na >30
SIADH, diuretics, adrenal insufficiency, hypothyroid, salt wasting
SIADH, diuretics, adrenal insufficiency, hypothyroid, salt wasting
- Labs: serum osm, urine osm, urine Na, glucose, BMP, TSH, AM cortisol, uric acid (low in SIADH), lipids/protein if pseudo.
- SIADH criteria: low serum osm, urine osm >100, urine Na >30, euvolemic, normal thyroid/adrenal/kidneys, no diuretics.
- SIADH causes: drugs (SSRIs, carbamazepine, thiazides, cyclophosphamide, MDMA), CNS disease, lung disease, small-cell cancer, pain, nausea, post-op.
Management
⌄
- 3% saline 100–150 mL over 10–20 min (or 2 mL/kg). Re-check Na. Repeat until symptoms improve (max ~3 boluses) or Na ↑ 4–6.
- Then stop and treat the cause.
- Rapid intermittent bolus (SALSA) ≈ continuous infusion for safety.
| Cause | Treatment |
|---|---|
| Hypovolemic | NS or LR. Risk: when volume returns, ADH shuts off → water diuresis → overcorrection |
| SIADH | Fluid restriction <800–1000 mL/day; stop drug; urea 15–30 g/day or salt tablets + furosemide; tolvaptan (specialist; avoid in liver disease) |
| HF / cirrhosis | Fluid restriction, loop diuretic, treat disease; avoid hypertonic unless severe symptoms |
| Low solute (beer potomania, tea & toast) | Give solute slowly (food). Very high ODS risk |
| Thiazide | Stop thiazide, replace K |
| Adrenal insufficiency | Hydrocortisone (Na rises fast after) |
- Na rose >8 (high risk) or >10–12 in 24 h →
- D5W (e.g., 3 mL/kg/h) + desmopressin 2 mcg IV/SC q6–8h to bring Na back down.
- Proactive "DDAVP clamp" for very high-risk patients (desmopressin + slow 3% saline).
Na change per 1 L of fluid (Adrogué-Madias) = (infusate Na + K − serum Na) ÷ (total body water + 1). Formulas often underestimate the rise — measure, do not trust the math.
Pitfalls
⌄
- NS in SIADH (urine osm higher than saline osm → Na can fall).
- Forgetting the K in IV fluids also raises Na.
- Leaving a patient on maintenance D5W with Na 124.
- Correcting too fast after a big water diuresis (hypovolemia, beer potomania, thiazide stop).
Board corner
⌄
| Stem | Answer |
|---|---|
| Na 118, seizure | 3% saline bolus |
| Euvolemic, U-osm 450, U-Na 50, lung mass | SIADH (small-cell) → fluid restriction, treat cause |
| Na 104, alcoholic, rose to 118 in 24 h | Overcorrection → D5W + DDAVP |
| Days after correction: dysarthria, quadriparesis | Osmotic demyelination |
| U-osm 60, drinks 10 L/day | Primary polydipsia |
| Na 128, glucose 900 | Translocational (corrected Na normal) |
References
⌄
- Spasovski G, et al. European clinical practice guideline on hyponatraemia. Eur J Endocrinol. 2014;170:G1.
- Verbalis JG, et al. US expert panel recommendations. Am J Med. 2013;126:S1.
- Baek SH, et al. SALSA trial. JAMA Intern Med. 2021;181:81.
- Adrogué HJ, Madias NE. Diagnosis and treatment of hyponatremia. JAMA. 2022.